Search Results 661-670 of 16024 for pharmacogenetics
Here's a look back at 10 (of many) of Mayo Clinic's influential precision medicine research studies of 2023. 1. Mayo Clinic organoid study reveals possible key ...
Selumetinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. It is not yet known whether temozolomide is more ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
About this study. The purpose of this study is to find out whether it is better to receive a new drug, BBI608, in addition to paclitaxel chemotherapy or ...
About this study. The purpose of this study is to assess the response rate (ORR) of patients with unresectable, pre-treated biliary cancers treated with the ...
ROCHESTER, Minn. – Mayo Clinic researchers are using precision genomics to search for undiscovered, inheritable genetic mutations that cause accelerated ...
Investigators in the Mayo Clinic Ovarian Cancer SPORE are exploring natural killer (NK) cells as an adoptive cellular therapy for ovarian cancer.
The purpose of this study is to collect blood samples for DNA analysis from patients clinically diagnosed with Alzheimers disease, Lewy Body disease, and ...
The purpose of this study is to investigate the effect of Avapritinib on the pharmacokinetics of Midazolam in patients with unresectable or metastatic ...
Pancreatitis and Acute Outcomes Research: Vijay P. · Parkinson's Disease and Movement Disorders: Charles H. · Parkinson's Disease: Owen A. · Pediatric Anxiety ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your GivingTuesday gift can go 2X as far.